Skip to content

Author

Reiko Sato

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

RSV Disease Burden in Adults in Emerging Market Countries, a Systematic Review and Modelling Analysis

The estimated incidence and proportion positive of RSV disease in EMC is substantially lower than HIC, and narrow case definitions requiring fever, less sensitive testing such as direct fluorescent antibody testing, reduced healthcare access, and incomplete surveillance may be contributing to these lower estimates.

Sebastien Kenmoe, B. Wahi-Singh, P. Wahi-Singh et al. · 0 citations
Open access Jul 2026

Cost-effectiveness of RSVpreF for the prevention of respiratory syncytial virus illness among high-risk adults in Germany.

Expanding the recommendation to include IC or CMC+/IC adults aged 18-59 years could substantially reduce the clinical burden of RSV-LRTI in Germany; including IC 18-59-year-olds would also be cost-saving.

Erin Quinn, M. MacKinnon, Severin Freisberg et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.